New Vernon Capital Holdings Ii LLC Embecta Corp. Transaction History

New Vernon Capital Holdings Ii LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.13 - $14.6 $128,154 - $184,704	-12,651 Reduced 80.39%	3,087 $38,000
Q1 2024 May 15, 2024	BUY	$12.35 - $19.33 $13,980 - $21,881	1,132 Added 7.75%	15,738 $208,000
Q4 2023 Feb 14, 2024	BUY	$12.87 - $19.09 $187,979 - $278,828	14,606 New	14,606 $276,000
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $1,661 - $2,359	72 New	72 $2,000

401

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.04B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.